rituximab
roche,biogen
['lymsm', 'rituximab', 'lymphoma']
congress| #eha2022 laurie h. sehn, discusses whether tafa + len and rituximab provides improved clinical benefit compared with len and rituximab in pts with r/r fl or mzl #lymphoma #lymsm #medicalcongress 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm